Upcoming webinars
Joint EBMT/ASTCT Pharmacy Journal Club - Model-based dosing of Antithymocyte globulin (ATG)
Join the EBMT Pharmacist Committee and the ASTCT Pharmacy SIG on Thursday, 29 January, from 16:00 to 17:00 CET, for our second joint virtual journal club.
This session will feature two complementary journal club presentations, with dedicated time for discussion and an interactive Q&A.
Moderators:
Nick Duncan (University Hospitals Birmingham) and Tatjana Grgic (University of North Carolina Medical Center)
Speakers:
Rick Admiraal (Princess Máxima Center for Pediatric Oncology) and Binni Kunvarjee (Memorial Sloan Kettering Cancer Center)
Our expert speakers will present following articles:
- Admiraal R, Nierkens S, Bierings MB, et al. Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial. Lancet Haematol. 2022 Feb;9(2):e111-e120. doi: 10.1016/S2352-3026(21)00375-6. PMID: 35114150.
- Admiraal R, Nierkens S, Bierings MB, et al. Improved survival with model-based dosing of antithymocyte globulin in pediatric hematopoietic cell transplantation. Blood Adv. 2025 May 13;9(9):2344-2353. doi: 10.1182/bloodadvances.2024014836. PMID: 39983052; PMCID: PMC12142804.
- Scordo M, Perales MA, Mauguen A, et al. Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study. Lancet Haematol. 2025 Dec;12(12):e956-e965. doi: 10.1016/S2352-3026(25)00293-5. PMID: 41338864.
Learning objectives:
By the end of the webinar, attendees should have an improved understanding of:
1. Toxicity and efficacy of ATG in relation to drug exposure
2. Model-based methods to optimize dosing in order to improve clinical outcome
3. Clinical application of model-informed ATG precision dosing
REGISTRATION OPEN!
Register in this link
Past webinars
Interactive Case Study on Prevention and Treatment of Fungal Infections in Stem Cell Transplant Patients
The EBMT Pharmacist Committee invited all colleagues with an interest in fungal infections to attend an interactive, case-based webinar focusing on the prevention and management of fungal infections in stem cell transplant recipients. The webinar was held on 23 October 2025 and was hosted by an expert panel of pharmacists. It included discussion of interesting clinical cases, followed by a panel discussion guided by questions raised by participants.
Moderator:
Mr Nick Duncan. Consultant Haematology Pharmacist. Queen Elizabeth Hospital, Birmingham, UK.
Learning objectives:
By the end of the webinar, you should be able to:
Describe risk categories and the role of risk stratification in the context of choosing antifungal prophylaxis
Discuss pros and cons of different systemic antifungals in the setting of prophylaxis and treatment of invasive fungal infection
Summarise pharmacokinetic issues, toxicity concerns and monitoring requirements for systemic antifungals
Therapeutic Drug Monitoring of Busulfan and other Conditioning Chemotherapy: Optimizing Dosing for Individualized Therapy
The webinar was organised by the Pharmacist Committee on 20 November covered the importance of Therapeutic Drug Monitoring (TDM) for conditioning agents in hematopoietic stem cell transplantation, mainly focussing on busulfan. It provided an overview of TDM guidance and discussed best practices for implementing TDM services at individual centers.
Speaker panel:
Moderator:
- Mr Nick Duncan. Consultant Haematology Pharmacist. Queen Elizabeth Hospital, Birmingham, UK.
Speaker:
- Rick Admiraal, MD PhD, Clinical Research Fellow Pediatric Oncology and Clinical Pharmacologist, Princess Maxima Center for Pediatric Oncology, Netherlands.
- Claudia Langebrake, Priv.-Doz. Dr. Clinical Pharmacist. University Medical Center Hamburg-Eppendorf, Hospital Pharmacy and Department of Stem Cell Transplantation. Germany.
- Vera Domingos, PharmD. Hospital Pharmacist, Instituto Português de Oncologia de Lisboa Francisco Gentil, Portugal.
- Maria-Estela Moreno-Martinez, Clinical Pharmacist, BCOP. Hospital de la Santa Creu i Sant Pau, Barcelona. Spain.
- Karen Sweiss, PharmD. Clinical Assistant Professor. Clinical Pharmacist in Hematology and Stem Cell Transplant. University of Illinois at Chicago. UI Health. Chicago, USA.
Sponsorship
There are various opportunities to support the EBMT Educational Webinars. For more information, please send an email to fundraising@ebmt.org